Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open, Randomized, Cross-over, Two Period, Two-sequence, One-center, Bioequivalence Study of Ibuprofen D, Oral Suspension, 200 mg / 5ml (Pharmtechnology, Belarus) and Nurofen® for Children, Oral Suspension 100 mg / 5 ml (Reckitt Benckiser Healthcare International Ltd, UK) in Healthy Volunteers Under Fasting Conditions

NCT03561558 is registered in ClinicalTrials.gov with Pharmtechnology LLC as lead sponsor.

NCT NCT03561558
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03561558 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open, Randomized, Cross-over, Two Period, Two-sequence, One-center, Bioequivalence Study of Ibuprofen D, Oral Suspension, 200 mg / 5ml (Pharmtechnology, Belarus) and Nurofen® for Children, Oral Suspension 100 mg / 5 ml (Reckitt Benckiser Healthcare International Ltd, UK) in Healthy Volunteers Under Fasting Conditions
Lead sponsor
Pharmtechnology LLC
Phase
Phase 1
Overall status
Completed
Start date
June 11, 2018
Completion date
June 25, 2018
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy